Menu Search
Equities

Transcenta Holding Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
6628:HKG.HS

Transcenta Holding Ltd

Actions
  • Price (HKD)2.33
  • Today's Change-0.07 / -2.92%
  • Shares traded249.00k
  • 1 Year change+232.86%
  • Beta0.8070
Data delayed at least 15 minutes, as of Feb 16 2026 03:55 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Transcenta Holding Ltd is a investment holding company engaged in the discovery, research, development, manufacturing and business development of biopharmaceuticals in the clinical stage. The Company's products include MSB2311, TST001, TST005, TST002, TST004, TST003, TST008, MSB0254 and TST006. The Company also provides contract development and manufacturing organization (CDMO) services, mainly including process development services, GMP / cGMP production services, cell line development services, sample testing services, formula optimization services and drug formation research.

  • Revenue in HKD (TTM)10.64m
  • Net income in HKD-301.33m
  • Incorporated2010
  • Employees171.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.